Overview

Study of Metastatic Ocular Melanoma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study evaluates treatment with combination versus monotherapy for patients with metastatic ocular melanoma.
Phase:
Phase 2
Details
Lead Sponsor:
Charite University, Berlin, Germany
Treatments:
Gemcitabine
Treosulfan